Cart
sales@molnova.com
Oroxin A (b)
CAS No. 31567-75-6
Oroxin A (b)( Baicalin-7-glucoside )
Catalog No. M20263 CAS No. 31567-75-6
Oroxin A is a partial PPARγ agonist that can activate PPARγ transcriptional activation in vitro and in vivo. Oroxin A also exhibited inhibitory activity against α-glucosidase and antioxidant capacity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 109 | In Stock |
|
| 50MG | 339 | In Stock |
|
| 100MG | 509 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOroxin A (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionOroxin A is a partial PPARγ agonist that can activate PPARγ transcriptional activation in vitro and in vivo. Oroxin A also exhibited inhibitory activity against α-glucosidase and antioxidant capacity.
-
DescriptionOroxin A is a partial PPARγ agonist that can activate PPARγ transcriptional activation in vitro and in vivo. Oroxin A also exhibited inhibitory activity against α-glucosidase and antioxidant capacity.
-
In Vitro——
-
In Vivo——
-
SynonymsBaicalin-7-glucoside
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPARγ agonist| α-glucosidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number31567-75-6
-
Formula Weight432.38
-
Molecular FormulaC21H20O10
-
Purity>98% (HPLC)
-
SolubilityDMSO: Soluble
-
SMILESOC[C@H]1O[C@@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sun W et al. Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice. Phytomedicine. 2018 Jan 1;38:24-34.
molnova catalog
related products
-
Reglitazar
Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
CGS 15435
CGS 15435 is a potent thromboxen (TxA2) synthetase inhibitor (IC50: 1 nM). CGS 15435 acts on PGI2 synthase, cyclooxygenase and liposynthase with much less selectivity than on thromboxin synthase.
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
